Accelrys (ACCL)
|
9.41
-0.04 (-0.42%)
|
|
|
|
ACCL additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACCL Profile
•
Exchange
NASDAQ
•
Top Holders (By Fund)
•
Executives
Mr. Scipio Carnecchia
Chief Exec. Officer
Pres and Director
Mr. Michael A. Piraino CPA
Chief Financial Officer
Principal Accounting Officer and Exec. VP
Mr. Anil Thakur
Sr. VP of Software Devel.
Dr. Stephen A. Spearman Ph.D. A
62
Exec. VP Chief Operating Officer of Pharmacopeia Drug Discovery Inc and Exec. VP of Pharmacopeia Drug Discovery Inc
Mr. David R. Mersten
Sr. VP
Gen. Counsel and Sec.
Chief Exec. Officer
Pres and Director
Mr. Michael A. Piraino CPA
Chief Financial Officer
Principal Accounting Officer and Exec. VP
Mr. Anil Thakur
Sr. VP of Software Devel.
Dr. Stephen A. Spearman Ph.D. A
62
Exec. VP Chief Operating Officer of Pharmacopeia Drug Discovery Inc and Exec. VP of Pharmacopeia Drug Discovery Inc
Mr. David R. Mersten
Sr. VP
Gen. Counsel and Sec.
•
Employee Count
601
Special Offers
Competitors
ACCL earnings
Date
Actual
Expected
Prev Yr Qtr
10/31/2012
0.11
0.10
0.10
8/2/2012
0.07
0.08
0.08
5/3/2012
0.08
0.06
0.08
